Arkolith/Insider Trading/AARD/Form 4

Lee Tien-Li

Chief Executive Officer, Director, 10% OwnerAardvark Therapeutics, Inc. (AARD) · full profile →Form 4 · filed Sep 12, 2025
Net Buying
Open-Market Buys
$161K
Open-Market Sells
$0
Net Open-Market Flow
$161K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2025Buy(P)5K$8.50$43K1.5M
Sep 11, 2025Buy(P)6K$7.82$47K1.5M
Sep 10, 2025Buy(P)9K$7.91$71K1.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-202490) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML